Wuya College of Innovation, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, 110016, China.
Adv Healthc Mater. 2023 Aug;12(21):e2203295. doi: 10.1002/adhm.202203295. Epub 2023 Apr 27.
Biocompatible polymer microneedles (MNs) are emerging as a promising platform for transdermal drug delivery, especially for facial treatments. Therefore, an MN patch in this study uses hydrolyzed collagen (HC) contained in skin cells as the main raw material and adopts a two-step cast method to develop a rapidly dissolving microneedle (DMN) to deliver collagen in a simple and minimally invasive way, allowing the release of the encapsulated drug in the skin. By optimizing the formulation and proportion of HC and auxiliary support materials, the mechanical strength required to pierce the skin is obtained, while the soft pedestal allows for flexibility in application. The DMNs can dissolve completely in the skin within 15 min and release within ≈ 8 h, and do not cause toxicity or irritation when being applied. In contrast to the ineffectiveness of oral and external application, and the high risk of dermal injection, drug-loaded DMNs overcome the drawbacks of traditional methods with direct penetration and minimally invasive manner, enabling efficient and safe treatment. The successful preparation and research of HC DMNs have innovative and practical significance in this field, and it is expected to become a simple, effective, and popular transdermal drug delivery platform for cosmetics.
生物相容聚合物微针 (MNs) 作为透皮药物输送的一种有前途的平台正在出现,特别是在面部治疗方面。因此,本研究中的 MN 贴片使用皮肤细胞中包含的水解胶原蛋白 (HC) 作为主要原料,并采用两步浇铸法开发一种快速溶解的微针 (DMN),以简单且微创的方式输送胶原蛋白,使包裹的药物在皮肤中释放。通过优化 HC 和辅助支撑材料的配方和比例,获得了刺穿皮肤所需的机械强度,而柔软的底座则使应用具有灵活性。DMNs 可在 15 分钟内在皮肤中完全溶解,并在 ≈ 8 小时内释放,并且在应用时不会引起毒性或刺激性。与口服和外部应用无效以及皮肤注射风险高相比,载药 DMNs 以直接穿透和微创的方式克服了传统方法的缺点,实现了高效和安全的治疗。HC DMNs 的成功制备和研究在该领域具有创新性和实际意义,有望成为一种简单、有效、流行的化妆品透皮药物输送平台。